Publication | Closed Access

Measurement of human cerebral monoamine oxidase type B (MAO-B) activity with positron emission tomography (PET): a dose ranging study with the reversible inhibitor Ro 19-6327

Positron Emission TomographyMedicineNeuropharmacologyNeurochemical BiomarkersNeurologyNeuroscienceReversible Inhibitor RoCerebral Blood FlowDopaminePharmacologyNeurochemistry